Gynatresia

Absence of a normal opening in the lumen of the female genital tract, from the FALLOPIAN TUBES to the VAGINA. This anomaly may be congenital or acquired due to injuries, diseases, or TISSUE ADHESIONS.

Drugs by status

Phase 4 trials (3)

dydrogesterone
autologous cd133+ stem cells
hyaluronic acid

Phase 2 trials (6)

esketamine
platelet-rich plasma
allogeneic hematopoietic stem cells
estradiol
autologous mesenchymal stem cells
remifentanil

Phase 1 trials (3)

plerixafor
amniotic epithelial cells
autologous adipose-derived mesenchymal stem cells

Other trials (2)

oxiplex
sodium chloride

Organizations

Organization Involved with Phase 4 Indications (2)

University of Valencia
Capital Medical University

Organization Involved with Phase 3 Indications (1)

University of Paris

Organization Involved with Phase 2 Indications (6)

Ain Shams University
Belarusian Medical Academy of Post-Graduate Education
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
University of California, San Francisco
Belarusian State Medical University
National Academy of Sciences of Belarus

Organization Involved with Other Experimental Indications (5)

Acibadem University
Baskent University
Tel Aviv University
University of Haifa
Hebrew University